Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chloé Iss
Observed names:
C. Iss,
Chloe Iss
Institution:
Molecular Partners (Switzerland)
Observed institutions:
Inserm,
Aix-Marseille Université,
Molecular Partners (Switzerland),
Communauté Université Grenoble Alpes,
Université Grenoble Alpes
ORCID:
0000-0002-0608-6816
Observed ORCID:
0000-0002-0608-6816
OpenAlex ID:
A5001613313
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants
2022
·
Sylvia Rothenberger
, Daniel L. Hurdiss
, et al.
·
Nature Biotechnology
·
77
PDF
Highly potent anti-SARS-CoV-2 multivalent DARPin therapeutic candidates
2020
·
Marcel Walser
, Sylvia Rothenberger
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
31
PDF
Engineering a Human-Like Glycosylation to Produce Therapeutic Glycoproteins Based on 6-Linked Sialylation in CHO Cells
2013
·
Nassimal El Maï
, Sandrine Donadio-Andréi
, et al.
·
Methods in molecular biology
·
22
The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
·
Cancer Immunology Research
·
17
PDF
Glycoengineering of protein-based therapeutics
2012
·
Sandrine Donadio-Andréi
, Chloé Iss
, et al.
·
Carbohydrate chemistry
·
6
Quelle pertinence accorder au taux circulant de TSH ?
2013
·
S. Donadio-Andréi
, K. Chikh
, et al.
·
Immuno-analyse & Biologie Spécialisée
·
4
Abstract 1890: A solution to T-cell engager toxicity: An anti-CD3 Prodrug DARPin (CD3-PDD) shows no toxicity, but potent anti-tumor activity in a humanized mouse model
2021
·
Andreas Bosshart
, Julia Katharina Ahlskog
, et al.
·
Cancer Research
·
3
Abstract 339: Development of 212Pb-based Radio-DARPin therapy (RDT) for the treatment of mesothelin (MSLN)-positive solid tumors
2025
·
Stephan Wullschleger
, Amal Saidi
, et al.
·
Cancer Research
·
1
Data from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Supplementary Figure S12 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
PDF
Supplementary Figure S1 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Supplementary Figure S16 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Supplementary Figure S2 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Supplementary Figure S15 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Supplementary Figure S3 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Supplementary Figure S5 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Supplementary Figure S13 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Supplementary Figure S17 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
PDF
Supplementary Figure S10 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Supplementary Figure S14 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
PDF
Supplementary Figure S4 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Supplementary Figure S4 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Supplementary Figure S18 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Supplementary Table S9 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Supplementary Table S6 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Show more works
View as search
Works count:
40
Citation count:
161
H-index:
5
I10-index:
4
Year
Topic
Type